Encoded Therapeutics

Drug Discovery

Encoded Therapeutics is a private drug discovery company. It was valued at $1.8 billion at its Series F in Sep 2026, the last priced event on record. It has raised $275 million across 2 recorded rounds; the latest was a $275 million Series F in Sep 2026.

PMV mark · valuation
$1.8B
Oct 2026
Priced at
its Series F
Sep 2026
Total raised
$275.0M
Last round
Series F
Sep 2026
How much has Encoded Therapeutics raised?
$275.0Macross 2 recorded rounds · Apr 2017 – Sep 2026

Most recently, Encoded Therapeutics raised $275.0M in its Series F (Sep 2026).

Free account
More of Encoded Therapeutics with a free account
  • ·The post-money valuation on its round
  • ·Watch Encoded Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Encoded Therapeutics round by round

2 rounds
Sep 2026Series F$275.0M▮
+ 9 more investors · free account
Apr 2017Accelerator/Incubatorundisclosed▮
+ 1 more investors · free account

How much has Encoded Therapeutics raised?

Encoded Therapeutics has raised $275 million across 2 recorded rounds since 2017. The largest was a $275 million Series F in Sep 2026. 1 of the rounds disclosed a post-money valuation.

Encoded Therapeutics investors

9 investors are on record for Encoded Therapeutics, including ARCH Venture Partners, Venrock, Illumina Ventures and RTW Investments. By type, the record holds 4 venture capital firms, 4 hedge funds and 1 family office. The Series F in Sep 2026 drew 12 investors.

For fundraisers
Raising for a company like Encoded Therapeutics?

9 investors have backed Encoded Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 9 investors →

Frequently asked about Encoded Therapeutics

How much has Encoded Therapeutics raised?
Encoded Therapeutics has raised $275.0M in total across 2 recorded funding rounds.
When was Encoded Therapeutics's last funding round?
Encoded Therapeutics's most recent recorded round was Series F in Sep 2026, raising $275.0M.